Cannabidiol for Treating PTSD symptoms and Neurocognitive Impairment in PTSD and PTSD Comorbid with TBI: A Placebo-controlled RCT with Neural-circuit centered Precision Medicine Prediction of Response.

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions:
    Traumatic Brain Injury
    Post Traumatic Stress Disorder
  • Age: Between 18 Year(s) - 85 Year(s)
  • Gender: Male or Female
  • Other Inclusion Criteria:
    1. DSM-5 current diagnosis of PTSD with the Clinician Administered PTSD Scale (CAPS-5)
    2. TBI present (for PTSD+TBI subjects only)
    3. Mild TBI (for PTSD+TBI subjects only)
    4. Able to provide at least 2 locators (cont

You may not be eligible for this study if the following are true:

    1. History of open head injury
    2. TBI within the last 6 months
    3. Moderate-severe TBI
    4. SUD in the last 6 months other than mild AUD or nicotine use
    5. Use of any cannabinoid containing product within the last

If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.